Form 8-K - Current report:
SEC Accession No. 0001558370-25-004264
Filing Date
2025-04-01
Accepted
2025-04-01 16:10:20
Documents
18
Period of Report
2025-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250331x8k.htm   iXBRL 8-K 46271
2 EX-4.1 chrs-20250331xex4d1.htm EX-4.1 26726
3 EX-99.1 chrs-20250331xex99d1.htm EX-99.1 22361
4 GRAPHIC chrs-20250331xex99d1001.jpg GRAPHIC 6665
  Complete submission text file 0001558370-25-004264.txt   276181

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20250331.xsd EX-101.SCH 4589
6 EX-101.DEF chrs-20250331_def.xml EX-101.DEF 3156
7 EX-101.LAB chrs-20250331_lab.xml EX-101.LAB 12262
8 EX-101.PRE chrs-20250331_pre.xml EX-101.PRE 11149
20 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250331x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 25799708
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)